Loan Loss Reserves / Non-Performing Loans (Quarterly)

Loan Loss Reserves / Non-Performing Loans: Allowance for bad loans as a portion of total loans made. Calculated as: Loan Loss Reserves / Non-Performing Loans

Kestra Medical Technologies, Ltd. (KMTS) Loan Loss Reserves / Non-Performing Loans data is not available.

Quarterly Annual

Figures for fiscal quarter ending 2025-10-31

Income Statement Financials
Revenue	$22.57M
Net Income	$-32.78M
Cost of Goods Sold	$11.14M
Gross Profit	$11.42M
Operating Expenses	$54.32M
Operating Income	$-31.75M
Non-Operating Income/Expense	$-1.00M
Pre-Tax Income	$-32.75M
Normalized Pre-Tax Income	$-32.75M
Income after Taxes	$-32.78M
Income from Continuous Operations	$-32.78M
Consolidated Net Income/Loss	$-32.78M
Normalized Income after Taxes	$-32.78M
EBIT	$-31.75M
EBITDA	$-28.91M
Weighted-Average Shares Outstanding (Basic)	51.38M
Weighted-Average Shares Outstanding (Diluted)	51.38M
Earnings per Share (EPS) (Basic)	$-0.64
Earnings per Share (EPS) (Diluted)	$-0.64
Balance Sheet Financials
Current Assets	$195.41M
Property, Plant, and Equipment	$45.93M
Long-Term Assets	$51.29M
Total Assets	$246.70M
Current Liabilities	$35.76M
Long-Term Debt	$41.87M
Long-Term Liabilities	$46.86M
Total Liabilities	$82.62M
Common Equity	$164.08M
Tangible Shareholders Equity	$164.08M
Shareholders Equity	$164.08M
Common Shares Outstanding	51.45M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-44.62M
Cash Flow from Investing Activities	$-15.65M
Cash Flow from Financial Activities	$-1.90M
Beginning Cash	$237.93M
End Cash	$175.76M
Increase/Decrease in Cash	$-62.17M
Stock-Based Compensation	$13.23M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	5.47
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.20
Debt to Equity Ratio	0.26
Gross Margin	50.63%
Operating Margin	-140.73%
EBIT Margin	-140.73%
EBITDA Margin	--
Pre-Tax Profit Margin	-145.14%
Profit Margin	-145.29%
Free Cash Flow	$-60.27M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.09
Inventory Turnover	--
Receiveable Turnover	2.17
Days Sales in Receivables	41.53
Return on Equity	-19.98%
Return on Tangible Equity	-19.98%
Return on Assets	-13.29%
Return on Investments	-15.92%
Book Value Per Share	$3.19
Free Cash Flow per Share	$-1.17
Operating Cash Flow per Share	$-0.87

Data from Zacks Investment Research, Inc.